Aelan Cell Technologies

Punctuating messages encoded in human genome with transposable elements

Recent study finds that Mammalian-wide Interspersed Repeats (MIRs) serve as genetic landmarks to target regulatory mechanisms, coordinating gene expression in cells. Boundary elements, encoded by MIRs, help establish the geography of genome packaging, controlling timing and extent of gene expression.

SourceAelan Cell Technologies·JournalProceedings of the National Academy of Sciences·DateAug 3, 2015

Aelan Cell Technologies publishes new research identifying biomarkers that could serve as companion diagnostics for patients being treated with IL-2

Researchers discovered that age affects the interaction between Interleukin-2 and human mesenchymal stem cells. In younger patients, IL-2 and MSCs work together to fight cancer, but older populations see impaired treatment outcomes.

SourceAelan Cell Technologies·JournalOncoTargets and Therapy·DateJul 14, 2015

US Equity Holdings secures funding to launch Aelan Cell Technologies

Aelan Cell Technologies is a biotech startup researching and developing innovative biomedical technologies and diagnostic tools. Led by Dr. Victoria Lunyak, the company aims to advance human health and longevity with its disruptive technologies.

SourceAelan Cell Technologies·DateJun 3, 2015